BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4291902)

  • 21. Some aspects of fatty acid oxidation in isolated fat-cell mitochondria from rat.
    Harper RD; Saggerson ED
    Biochem J; 1975 Dec; 152(3):485-94. PubMed ID: 1227502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethanol and metyrapone effect on the redox potential, its compartimentalization, and its relation to the high energy phosphates of the rat liver in vivo.
    Dal Pra P; Melosi P; Rossini L
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:162-. PubMed ID: 4403295
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemia.
    Kuroda M; Tanzawa K; Tsujita Y; Endo A
    Biochim Biophys Acta; 1977 Oct; 489(1):119-25. PubMed ID: 911870
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of extended hypocholesterolemic drug treatment on peripheral and central nervous system sterol content of the rat.
    Ramsey RB
    Lipids; 1977 Oct; 12(10):841-6. PubMed ID: 72342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sterols and other lipids in tumors of the nervous system.
    Weiss JF
    Prog Biochem Pharmacol; 1975; 10():227-68. PubMed ID: 1093208
    [No Abstract]   [Full Text] [Related]  

  • 26. An ultrastructural and biochemical study of the effects of three inhibitors of cholesterol biosynthesis upon murine adrenal gland and testis. Histochemical evidence for a lysosome response.
    Dietert SE; Scallen TJ
    J Cell Biol; 1969 Jan; 40(1):44-60. PubMed ID: 5782451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CORRELATION OF DRUG CONCENTRATION WITH STEROL BIOSYNTHESIS INHIBITION IN THE LIVER.
    FIGDOR SK; SCHREIBER EC; STEBBINS RB; MOORE PF; PINSON R
    J Med Chem; 1964 Jul; 7():508-10. PubMed ID: 14221136
    [No Abstract]   [Full Text] [Related]  

  • 28. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.
    Netter KJ; Illing HP
    Xenobiotica; 1974 Sep; 4(9):549-61. PubMed ID: 4372813
    [No Abstract]   [Full Text] [Related]  

  • 29. A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis.
    Lindquist C; Bjørndal B; Rossmann CR; Svardal A; Hallström S; Berge RK
    PLoS One; 2018; 13(3):e0194978. PubMed ID: 29590220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased secretion of triglyceride and cholesterol following inhibition of long-chain fatty acid oxidation in rat liver.
    Yamamoto K; Fukuda N; Fukui M; Kai Y; Ikeda H; Sakai T
    Ann Nutr Metab; 1996; 40(3):157-64. PubMed ID: 8862698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excretory products of the sterol biosynthetic pathway in the MER-29-treated rat. Excretion of MER-29.
    BLOHM TR; KARIYA T; MACKENZIE RD
    Prog Cardiovasc Dis; 1960 May; 2():519-23. PubMed ID: 13801563
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug induced modifications of brain sterol composition in growing rats.
    Fumagalli R; Niemiro R; Paoletti R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):168-9. PubMed ID: 4232661
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mechanism of the lipotropic action of choline and possible participation of phospholipids in fatty acid oxidation].
    Vasil'eva ED
    Usp Sovrem Biol; 1975; 79(3):371-86. PubMed ID: 1103500
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluoroacetylcarnitine: metabolism and metabolic effects in mitochondria.
    Bremer J; Davis EJ
    Biochim Biophys Acta; 1973 Nov; 326(2):262-71. PubMed ID: 4765103
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of fatty acid oxidation by intramitochondrial [NADH]/[NAD+] in developing rat small intestine.
    Kimura RE; Warshaw JB
    Pediatr Res; 1988 Mar; 23(3):262-5. PubMed ID: 3353171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the inhibitory mechanism of some hypocholesterolemic agents on 7-dehydrocholesterol delta-7-bond reductase activity.
    Niemiro R; Fumagalli R
    Biochim Biophys Acta; 1965 Jun; 98(3):624-31. PubMed ID: 4284414
    [No Abstract]   [Full Text] [Related]  

  • 37. Erucic acid--an inhibitor of fatty acid oxidation in the heart.
    Christophersen BO; Bremer J
    Biochim Biophys Acta; 1972 Dec; 280(4):506-14. PubMed ID: 4648780
    [No Abstract]   [Full Text] [Related]  

  • 38. Fatty acid oxidation in embryonic chick tissues.
    Pugh E; Sidbury JB
    Biochim Biophys Acta; 1971 Sep; 239(3):376-83. PubMed ID: 5113500
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of hypocholesterolemic drugs on adrenal corticosteroid secretion.
    Huffman DH; Azarnoff DL
    Steroids; 1967 Jan; 9(1):41-51. PubMed ID: 6030919
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of carnitine in intracellular metabolism.
    Bremer J
    J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.